PT-141 10mg

PT-141 10mg Research Peptide

PT-141, also known as bremelanotide, is a synthetic melanocortin-receptor agonist supplied exclusively for laboratory and in vitro research.

The compound is investigated in research relating to melanocortin-receptor interactions, MC3R/MC4R-associated signalling and neuroendocrine pathways.

Published investigations remain experimental and do not establish suitability, safety or effectiveness for human or veterinary use.

PT-141 identity and related research materials

The listing uses PT-141 and bremelanotide as names for the research compound and specifies an amount of 10mg. When matching documentation, check the identity and batch reference rather than relying only on an abbreviation.

The Melanotan II research-material listing describes a separate compound in the broader melanocortin research area. A shared research pathway does not make the compounds interchangeable or establish equivalent specifications.

Review available product and batch documentation. Coverage varies; check that the record matches the material you are considering.

---

Research Areas

• Melanocortin-receptor research
• MC3R/MC4R-associated pathways
• Receptor-binding investigations
• Neuroendocrine-signalling studies
• Central-signalling research models

---

Documentation and Research Planning

PT-141 is also known as bremelanotide. Consult the available product documentation when checking the identity and specification of the research material. See the UK shipping policy for delivery information.

Important Research Use Notice

This product is supplied strictly for laboratory and in vitro research purposes only.
Not for human consumption.
Not for veterinary use.
Not for medical, therapeutic, diagnostic or administration purposes.